Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Thomas Massie introduces bill to pull US out...
JOHN YOO: Supreme Court showdown exposes shaky case...
South Korean K-pop stars BTS hit the right...
Nancy Mace vows to ‘fight like hell’ to...
DOJ cleared to release secret Jeffrey Epstein case...
Democrat John Fetterman decries ‘dehumanizing’ attack against Charlie...
US Chamber of Commerce accused of leading ‘woke...
Judge blocks Trump National Guard deployment in Los...
Lavrov warns Europe of retaliation as Zelenskyy opens...
Senate GOP barrels past blockade to advance nearly...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
The Hitchhiker’s Guide to where we stand to avoid a government shutdown
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

Judge Merchan sued for financial disclosures amid concerns...

September 5, 2024

US companies secure record $170B in global contracts...

September 30, 2025

Trump campaign clarifies after candidate jokes about shooting...

November 4, 2024

Opponents of antisemitism on campus frustrated by Schumer’s...

November 2, 2024

Here’s the speech Biden should have given to...

October 4, 2024

Who could run to replace Stefanik in the...

November 12, 2024

‘Tragic and shocking’: Explosive House report details ‘preventable’...

October 21, 2024

Jimmy Carter’s funeral will bring all five living...

January 9, 2025

Trump slams mail-in ballots as corrupt, but may...

August 20, 2025

JD Vance champions ‘roadmap’ toward US-India trade deal,...

April 22, 2025

Recent Posts

  • Thomas Massie introduces bill to pull US out of NATO: ‘America should not be the world’s security blanket’
  • JOHN YOO: Supreme Court showdown exposes shaky case against birthright citizenship
  • South Korean K-pop stars BTS hit the right note of how to wield cultural power
  • Nancy Mace vows to ‘fight like hell’ to rename old Black Lives Matter Plaza for Charlie Kirk
  • DOJ cleared to release secret Jeffrey Epstein case grand jury materials

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (963)
    • Investing (3,628)
    • Politics (4,387)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.